CD274 and triple-negative breast carcinoma: Correction: Therapeutic potential of isochlorogenic acid A from &lt;i&gt;Taraxacum officinale&lt;/i&gt; in improving immune response and enhancing the efficacy of PD-1/PD-L1 blockade in triple-negative breast cancer.